Insights in Acute Myeloid Leukemia: Optimizing System Level Quality for Our Veterans

Insights in Acute Myeloid Leukemia: Optimizing System Level Quality for Our Veterans is organized by Med Learning Group.,Release Date: May 26, 2022,Expiration Date: May 26, 2023,Program Overview:,This activity will explore the management of patients with newly diagnosed and relapsed/refractory acute myeloid leukemia (AML). This program will address the role of genetic and molecular markers in treatment selection as well as best practices for treatment of newly diagnosed, relapsed/refractory, and secondary AML. A summary of approaches to TRAE recognition and mitigation will also be discussed.,Learning Objectives:,Upon the completion of this program, attendees should be able to:,• Evaluate the role of genetic and molecular markers in treatment options for patients with AML,• Assess best practices for clinical management of newly diagnosed, and relapsed/refractory AML, as well as secondary AML, and implement shared decision-making across treatment plans,• Summarize possible adverse events associated with AML treatment and understand best practices for identification and management of potential adverse events